CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity
- 15 March 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (6) , 3095-3101
- https://doi.org/10.4049/jimmunol.164.6.3095
Abstract
The fate of dendritic cells (DC) after they have initiated a T cell immune response is still undefined. We have monitored the migration of DC labeled with a fluorescent tracer and injected s.c. into naive mice or into mice with an ongoing immune response. DC not loaded with Ag were detected in the draining lymph node in excess of 7 days after injection with maximum numbers detectable ∼40 h after transfer. In contrast, DC that had been loaded with an MHC class I-binding peptide disappeared from the lymph node with kinetics that parallel the known kinetics of activation of CD8+ T cells to effector function. In the presence of high numbers of specific CTL precursors, as in TCR transgenic mice, DC numbers were significantly decreased by 72 h after injection. The rate of DC disappearance was extremely rapid and efficient in recently immunized mice and was slower in “memory” mice in which memory CD8+ cells needed to reacquire effector function before mediating DC elimination. We also show that CTL-mediated clearance of Ag-loaded DC has a notable effect on immune responses in vivo. Ag-specific CD8+ T cells failed to divide in response to Ag presented on a DC if the DC were targets of a pre-existing CTL response. The induction of antitumor immunity by tumor Ag-loaded DC was also impaired. Therefore, CTL-mediated clearance of Ag-loaded DC may serve as a negative feedback mechanism to limit the activity of DC within the lymph node.Keywords
This publication has 29 references indexed in Scilit:
- A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitroEuropean Journal of Immunology, 1997
- A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.The Journal of Experimental Medicine, 1996
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIVNature, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Tolerance induction in double specific T-cell receptor transgenic mice varies with antigenNature, 1989
- Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.The Journal of Experimental Medicine, 1989
- Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues.The Journal of Experimental Medicine, 1988
- Characterization of nonlymphoid cells derived from rat peripheral lymphThe Journal of Experimental Medicine, 1983